Author: Brenda Marie Rivers|| Date Published: August 5, 2020
Smiths Detection has concluded its acquisition of Baltimore, Md.-based pathogen detection technology provider PathSensors one month after the deal was initially announced.
Roland Carter, president of Smiths Detection, said in a statement released Tuesday the company considers the transaction as a "strategic step" to accelerate its biological threat response efforts.
Carter added that PathSensors has multiple assay products built to help customers identify potential biothreats in a matter of minutes.
C5MI has appointed Garth Sanginiti as chief growth officer, the Jacksonville Beach, Florida-based company announced Tuesday. What Will Sanginiti Do as Chief…
SOSi has been awarded a position on a $100 million indefinite-delivery/indefinite-quantity contract to provide strategic and technical services for the Enhanced…